Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01641120 · ClinicalTrials.gov registry record · NA
Assessing Tolerability of Avonex Intramuscular Injections
A NA study, sponsored by Trinity Health Of New England.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01641120 is a NA study that has completed, run by Trinity Health Of New England. The registered enrollment target is 20 participants.
The verdict
NCT01641120, a NA study, has completed, sponsored by Trinity Health Of New England.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate patients' views when injecting Avonex intramuscularly.
Interventions
- DRUG Avonex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-05 |
| Est. Completion | 2014-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01641120
The ClinicalTrials.gov registry entry for NCT01641120 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Trinity Health Of New England, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Avonex is the first listed.
NCT01641120 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01641120 about?
NCT01641120 is a clinical study titled "Assessing Tolerability of Avonex Intramuscular Injections". The purpose of this study is to evaluate patients' views when injecting Avonex intramuscularly.
What is the current status of trial NCT01641120?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2012-05. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01641120?
The interventions under investigation include: Avonex (DRUG).
Who is sponsoring clinical trial NCT01641120?
This trial is sponsored by Trinity Health Of New England, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.